183 related articles for article (PubMed ID: 23152373)
1. Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia.
Goldberg RB; Rosenson RS; Hernandez-Triana E; Misir S; Jones MR
Diab Vasc Dis Res; 2013 May; 10(3):256-62. PubMed ID: 23152373
[TBL] [Abstract][Full Text] [Related]
2. Effect of colesevelam HCl monotherapy on lipid particles in type 2 diabetes mellitus.
Rosenson RS; Rigby SP; Jones MR; Chou HS
Cardiovasc Drugs Ther; 2014 Jun; 28(3):229-36. PubMed ID: 24710760
[TBL] [Abstract][Full Text] [Related]
3. Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes.
Rosenstock J; Hernandez-Triana E; Handelsman Y; Misir S; Jones MR
Postgrad Med; 2012 Jul; 124(4):14-20. PubMed ID: 22913890
[TBL] [Abstract][Full Text] [Related]
4. Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.
Goldberg RB; Rosenson RS; Hernandez-Triana E; Misir S; Jones MR
J Clin Lipidol; 2012; 6(4):318-24. PubMed ID: 22836068
[TBL] [Abstract][Full Text] [Related]
5. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
Davidson MH; Donovan JM; Misir S; Jones MR
Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
[TBL] [Abstract][Full Text] [Related]
6. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ;
Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231
[TBL] [Abstract][Full Text] [Related]
7. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
[TBL] [Abstract][Full Text] [Related]
8. Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia.
Rosenson RS
Atherosclerosis; 2006 Apr; 185(2):327-30. PubMed ID: 16009365
[TBL] [Abstract][Full Text] [Related]
9. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
10. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
11. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
Bays H; Rhyne J; Abby S; Lai YL; Jones M
Curr Med Res Opin; 2006 Nov; 22(11):2191-200. PubMed ID: 17076980
[TBL] [Abstract][Full Text] [Related]
12. Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes.
Handelsman Y; Abby SL; Jin X; Donovan JM; Jones MR
Postgrad Med; 2009 Nov; 121(6):62-9. PubMed ID: 19940418
[TBL] [Abstract][Full Text] [Related]
13. The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
Soedamah-Muthu SS; Colhoun HM; Thomason MJ; Betteridge DJ; Durrington PN; Hitman GA; Fuller JH; Julier K; Mackness MI; Neil HA;
Atherosclerosis; 2003 Apr; 167(2):243-55. PubMed ID: 12818407
[TBL] [Abstract][Full Text] [Related]
14. Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.
Rosenson RS; Abby SL; Jones MR
Atherosclerosis; 2009 Jun; 204(2):342-4. PubMed ID: 18996525
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
Knapp HH; Schrott H; Ma P; Knopp R; Chin B; Gaziano JM; Donovan JM; Burke SK; Davidson MH
Am J Med; 2001 Apr; 110(5):352-60. PubMed ID: 11286949
[TBL] [Abstract][Full Text] [Related]
16. Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis.
Siddiqui MS; Van Natta ML; Connelly MA; Vuppalanchi R; Neuschwander-Tetri BA; Tonascia J; Guy C; Loomba R; Dasarathy S; Wattacheril J; Chalasani N; Sanyal AJ;
J Hepatol; 2020 Jan; 72(1):25-33. PubMed ID: 31634532
[TBL] [Abstract][Full Text] [Related]
17. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia.
van der Graaf A; Rodenburg J; Vissers MN; Hutten BA; Wiegman A; Trip MD; Stroes ES; Wijburg FA; Otvos JD; Kastelein JJ
J Pediatr; 2008 Jun; 152(6):873-8. PubMed ID: 18492534
[TBL] [Abstract][Full Text] [Related]
18. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).
Bays HE; Braeckman RA; Ballantyne CM; Kastelein JJ; Otvos JD; Stirtan WG; Soni PN
J Clin Lipidol; 2012; 6(6):565-72. PubMed ID: 23312052
[TBL] [Abstract][Full Text] [Related]
19. Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study).
Ballantyne CM; Braeckman RA; Bays HE; Kastelein JJ; Otvos JD; Stirtan WG; Doyle RT; Soni PN; Juliano RA
J Clin Lipidol; 2015; 9(3):377-83. PubMed ID: 26073397
[TBL] [Abstract][Full Text] [Related]
20. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women.
Halverstadt A; Phares DA; Wilund KR; Goldberg AP; Hagberg JM
Metabolism; 2007 Apr; 56(4):444-50. PubMed ID: 17378998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]